Aceso Life Science Group Limited will convene its annual general meeting on 16 September 2026 at 10:30 a.m. on the 25th floor of Shui On Centre, Wanchai, Hong Kong.
Key resolutions to be tabled include:
1. Financial Statements • Shareholders will review and approve the audited consolidated financial statements and the directors’ and independent auditors’ reports for the fiscal year ended 31 March 2026.
2. Board Composition and Remuneration • Re-election of Mr Fok Chi Tak as Executive Director and Mr Mak Yiu Tong as Independent Non-executive Director. • Authorisation for the board to determine directors’ remuneration.
3. Auditor Appointment • Proposal to re-appoint Moore CPA Limited as independent auditors, with authority for the board to set audit fees.
4. Capital Management Mandates • General Share Issue Mandate: Directors may allot, issue or transfer treasury shares up to 20% of the company’s issued share capital (excluding treasury shares) during the mandate period, covering new issues, convertible securities and share option exercises, but excluding rights issues and scrip dividends. • Share Repurchase Mandate: Directors may repurchase up to 10% of the issued shares (excluding treasury shares) on the Hong Kong Stock Exchange, in line with Cayman Islands law and HKEX Listing Rules. • Mandate Extension: The number of shares repurchased under the above authority can be added to the 20% general issue limit, effectively allowing issuance of up to an additional 10% of share capital if the buy-back mandate is fully utilised.
5. Entitlement and Proxy Arrangements • The register of members will be closed from 11 September 2026 to 16 September 2026, both days inclusive. Shareholders must lodge share transfers by 4:30 p.m. on 10 September 2026 to qualify for AGM attendance and voting. • Proxy forms must be submitted to Computershare Hong Kong Investor Services Limited no later than 48 hours before the meeting.
Board Composition (as of the notice date): Executive Directors Dr Zhiliang Ou and Mr Fok Chi Tak; Non-executive Director Ms Jiang Yang; Independent Non-executive Directors Mr Chan Ming Sun Jonathan, Mr Lam Kwan Sing and Mr Mak Yiu Tong.
All proposed resolutions will require ordinary shareholder approval at the AGM.